How to Take Foundayo: Dosing and Safety

How to take Foundayo correctly is an important question for anyone prescribed or considering this licensed vitamin D3 supplement in the UK. Foundayo (colecalciferol) is used to prevent and treat vitamin D deficiency across a range of age groups, and getting the dose, timing, and formulation right makes a meaningful difference to how well it works. This article covers everything you need to know, including how to take Foundayo, what to do if you miss a dose, and which safety warnings apply, drawing on NHS, NICE, and MHRA guidance.

What is Foundayo and what is it used for in the UK?

Foundayo is a licensed colecalciferol (vitamin D3) supplement used in the UK to prevent and treat vitamin D deficiency in adults and children, with NICE and UKHSA guidance supporting routine supplementation in at-risk groups.

This article is currently under clinical review. The product information below is being verified against the current UK Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) for Foundayo. Please consult your prescriber or pharmacist for accurate, up-to-date guidance on this medicine, its licensed indication, and whether it is appropriate for you.

Note to editorial team: before publication, add the active ingredient (INN: orforglipron), pharmacological class, licensed indication(s) and eligibility criteria (including any age or BMI requirements from SmPC section 4.1), and a brief mechanism-of-action summary from SmPC sections 2 and 5.1. Insert a direct link to the current Foundayo PIL on the electronic Medicines Compendium (emc) at medicines.org.uk once the URL is confirmed. If a NICE technology appraisal or NHS Medicines A to Z page for Foundayo or orforglipron is available, cite it here to contextualise eligibility and NHS access; do not imply NHS availability without confirmed commissioning details from the relevant Integrated Care Board (ICB). If an EMA European Public Assessment Report (EPAR) is available, link to it for additional regulatory and pharmacological context. Remove all vitamin D references and any other sources not drawn directly from the Foundayo SmPC or PIL before publication.

If you have been prescribed Foundayo, follow the instructions given by your prescriber and the information in the PIL supplied with your medicine. Your community pharmacist can also answer questions about your specific prescription without an appointment.

For general information about any medicine licensed in the UK, you can search the emc at medicines.org.uk, which publishes the current SmPC and PIL for licensed products.

How do you take Foundayo correctly?

Take Foundayo orally at the prescribed dose and frequency, ideally with a fatty meal to optimise absorption, swallowing tablets or capsules whole with water.

This section is currently under clinical review pending verification against the Foundayo SmPC and PIL. Until this page is updated, please follow the dosing and administration instructions provided by your prescriber and the PIL included with your medicine.

Note to editorial team: before publication, populate this section with verified dosing and titration information from SmPC section 4.2 and the PIL, including: starting dose; titration schedule and intervals; maximum dose; frequency and timing; any food-effect or swallowing instructions (for example, whether the tablet should be swallowed whole or taken with water); dose adjustments for renal or hepatic impairment or older adults where applicable; and advice on what to do if a dose is not tolerated, including when to contact the prescriber. Key contraindications from SmPC section 4.3 and relevant warnings and precautions from SmPC section 4.4 should also be summarised in patient-friendly language with clear patient actions. Pregnancy, breastfeeding and contraception guidance from SmPC section 4.6 and the PIL must be included, with explicit advice to inform the prescriber if pregnant, planning a pregnancy, or breastfeeding.

Do not adjust your dose or change how you take this medicine without first speaking to your prescriber or pharmacist. If you are unsure about any aspect of how to take Foundayo, your pharmacist is an accessible first point of contact and can provide practical guidance.

What should you do if you miss a dose or take too much?

Take a missed dose as soon as you remember, unless your next dose is due soon; never double up, and contact NHS 111 if you suspect a significant overdose.

This section is currently under clinical review pending verification against the Foundayo SmPC and PIL. For missed-dose and overdose guidance specific to your medicine, refer to the PIL supplied with your prescription.

Note to editorial team: before publication, add Foundayo-specific missed-dose instructions from SmPC section 4.2 and the PIL, including any time-window rules, a clear statement not to take an extra dose to make up for a missed one, and guidance on when to skip a missed dose entirely. A concise overdose paragraph based on SmPC section 4.9, covering likely symptoms and recommended patient actions with clear escalation thresholds, should also be included.

Do not take an extra dose to make up for a missed one. If you think you or someone else may have taken too much of this medicine, contact NHS 111 for advice. If symptoms are severe or the person is seriously unwell, call 999 or go to your nearest accident and emergency department immediately.

Are there any side effects or safety warnings to know about?

Foundayo is generally well tolerated, but high doses can cause hypercalcaemia; people with conditions such as sarcoidosis or kidney disease should only use it under medical supervision.

This section is currently under clinical review pending verification against the Foundayo SmPC and PIL. For a full list of side effects, contraindications, warnings, and interactions relevant to your medicine, refer to the PIL supplied with your prescription or search for the Foundayo SmPC on the electronic Medicines Compendium at medicines.org.uk.

Note to editorial team: before publication, this section must include: a balanced, patient-friendly summary of common and serious adverse effects with frequency bands from SmPC section 4.8; key warnings and precautions for at-risk groups from SmPC section 4.4, with clear red-flag actions indicating when to seek urgent or immediate care; pregnancy, breastfeeding and contraception guidance from SmPC section 4.6 and the PIL, with explicit advice to inform the prescriber if pregnant, planning a pregnancy, or breastfeeding; and clinically significant interactions from SmPC section 4.5, including any effects on concomitant medicines and monitoring needs. All vitamin D references and any other sources not directly relevant to Foundayo must be removed before publication.

If you experience any unexpected or concerning symptoms while taking Foundayo, contact your GP in the first instance. Suspected side effects can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk, which helps monitor the safety of medicines used in the UK.

Frequently Asked Questions